These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 3054922
21. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. Gebauer G, Müller-Ruchholtz W. Anticancer Res; 1997; 17(4B):2939-42. PubMed ID: 9329569 [Abstract] [Full Text] [Related]
24. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance. Gebauer G, Müller-Ruchholtz W. Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706 [Abstract] [Full Text] [Related]
26. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence. Holubec L, Topolcan O, Pikner R, Pecen L, Vaclavickova J, Wirthova M, Molacek J, Stieber P, Holdenrieder S, Sen LH, Finek J. Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702 [Abstract] [Full Text] [Related]
31. Serum tumor markers in colorectal cancer staging, grading, and follow-up. Plebani M, De Paoli M, Basso D, Roveroni G, Giacomini A, Galeotti F, Corsini A. J Surg Oncol; 1996 Aug 15; 62(4):239-44. PubMed ID: 8691835 [Abstract] [Full Text] [Related]
32. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9. Quentmeier A, Schlag P, Geisen HP, Schmidt-Gayk H. Eur J Surg Oncol; 1987 Jun 15; 13(3):197-201. PubMed ID: 3474158 [Abstract] [Full Text] [Related]
33. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups]. Wählby L. Lakartidningen; 1997 Apr 30; 94(18):1716-8. PubMed ID: 9182180 [No Abstract] [Full Text] [Related]
34. Targeted colon cancer screening: a concept whose time has almost come. Lieberman DA. Am J Gastroenterol; 1992 Sep 30; 87(9):1085-93. PubMed ID: 1519564 [Abstract] [Full Text] [Related]
35. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Tanaka T, Kojima T, Suzui M, Mori H. Cancer Res; 1993 Sep 01; 53(17):3908-13. PubMed ID: 8358716 [Abstract] [Full Text] [Related]
37. [The CEA-concentration in plasma of patients with colorectal carcinoma and polyps has been determined by radioimmunoassay (RIA, Z-gel-method)]. Ziegenbein R, Jacobasch KH, Pilgrim G, Seifart W. Arch Geschwulstforsch; 1980 Sep 01; 50(2):165-8. PubMed ID: 7436700 [Abstract] [Full Text] [Related]
39. Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer. Eskelinen M, Pasanen P, Kulju A, Janatuinen E, Miettinen P, Poikolainen E, Tarvainen R, Nuutinen P, Pääkkönen M, Alhava E. Anticancer Res; 1994 Sep 01; 14(3B):1427-32. PubMed ID: 8067718 [Abstract] [Full Text] [Related]
40. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D, Nürnberg R, Bahlo M, Klapdor R. Anticancer Res; 1999 Sep 01; 19(4A):2443-50. PubMed ID: 10470173 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]